Skip to main content

Table 3 Clinical Outcomes

From: Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study

 

FVIIa group (n = 45)

Comparison Group (n = 34)

p-value

Mean INR at 3 h

0.98 [0.90 – 1.06]

1.63 [1.40 – 1.86]

0.0001

Mean INR at 6 hours

1.10 [1.00 – 1.20]

1.51 [1.41 – 1.61]

<0.0001

Mean units of FFP transfused

3 [2.1 – 3.9]

5 [3.6 – 6.3]

0.003

Surgical hematoma evacuation

17 (38%)

6 (18%)

0.05

Survival after surgical hematoma evacuation

14 (31%)

4 (12%)

0.04

In-hospital death

16 (36%)

6 (18%)

0.07

Withdrawal of life-prolonging care

14 (31%)

6 (18%)

0.17